E-LIB Suche - Ergebnisse für: Bratton, Daniel J

1

Clinical characterisation of exacerbations of severe eosino..:

Howell, Imran ; Bratton, Daniel J ; Hynes, Gareth...
ERJ Open Research. , 2024

2

Facilities for optimizing and designing multiarm multistage..:

Choodari-Oskooei, Babak ; Bratton, Daniel J. ; Parmar, Mahesh K. B.
The Stata Journal: Promoting communications on statistics and Stata. 23 (2023) 3 - p. 774-798 , 2023

Link: https://doi.org/10.1177/..

3

Patient‐Reported Outcome Measures for Severe Recurrent Bila..:

Gater, Adam ; Tolley, Chloe ; Williams‐Hall, Rebecca...
OTO Open. 7 (2023) 4 - p. , 2023

Link: https://doi.org/10.1002/..

4

Comments on "Emerging insights and commentaries – MMRM vs L..:

Wright, David ; Bratton, Daniel J. ; Drury, Thomas...
Journal of Biopharmaceutical Statistics. 34 (2023) 1 - p. 146-148 , 2023

Link: https://doi.org/10.1080/..

5

Mepolizumab improves work productivity, activity limitation..:

Albers, Frank C. ; Bratton, Daniel J. ; Gunsoy, Necdet B....
The Clinical Respiratory Journal. 16 (2022) 3 - p. 252-258 , 2022

Link: https://doi.org/10.1111/..

6

Comment on: Pairwise indirect treatment comparison of dupil..:

Martin, Neil ; Papi, Alberto ; Bratton, Daniel J....
Respiratory Medicine. 191 (2022) - p. 106065 , 2022

Link: https://doi.org/10.1016/..

7

Response to mepolizumab treatment is sustained across 4-wee..:

Pavord, Ian D. ; Bleecker, Eugene R. ; Buhl, Roland...
ERJ Open Research. 6 (2020) 3 - p. 00068-2020 , 2020

Link: https://doi.org/10.1183/..

8

Adding new experimental arms to randomised clinical trials:..:

Choodari-Oskooei, Babak ; Bratton, Daniel J ; Gannon, Melissa R...
Clinical Trials. 17 (2020) 3 - p. 273-284 , 2020

Link: https://doi.org/10.1177/..

9

Severe eosinophilic asthma with nasal polyposis: A phenotyp..:

Howarth, Peter ; Chupp, Geoffrey ; Nelsen, Linda M....
Journal of Allergy and Clinical Immunology. 145 (2020) 6 - p. 1713-1715 , 2020

Link: https://doi.org/10.1016/..

10

Subgroup Analysis: A View from Industry:

, In: Emerging Topics in Statistics and Biostatistics; Design and Analysis of Subgroups with Biopharmaceutical Applications,

Keene, Oliver N. ; Bratton, Daniel J. - p. 309-330 , 2020

Link: https://doi.org/10.1007/..

11

Baseline blood eosinophil count as a predictor of treatment..:

Albers, Frank C. ; Licskai, Christopher ; Chanez, Pascal...
Respiratory Medicine. 159 (2019) - p. 105806 , 2019

Link: https://doi.org/10.1016/..

12

Reply:

Gunsoy, Necdet B. ; Bratton, Daniel J. ; Albers, Frank C..
Journal of Allergy and Clinical Immunology. 143 (2019) 3 - p. 1267-1268 , 2019

Link: https://doi.org/10.1016/..

13

Efficacy Of 100 Mg SC Mepolizumab For Severe Eosinophilic A..:

Bradford, Eric S. ; Taillé, Camille ; Bratton, Daniel J....
Journal of Allergy and Clinical Immunology. 143 (2019) 2 - p. AB102 , 2019

Link: https://doi.org/10.1016/..

14

Update: Mepolizumab treatment in patients with severe eosin..:

Albers, Frank C. ; Hozawa, Soichiro ; Bratton, Daniel J....
Allergy. 75 (2019) 4 - p. 942-946 , 2019

Link: https://doi.org/10.1111/..

15

Mepolizumab reduces exacerbations in patients with severe e..:

Albers, Frank C. ; Papi, Alberto ; Taillé, Camille...
Respiratory Research. 20 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..